The "Proteomic Biomarker Analytics Markets. Forecasts by Application, Technology, Product and Place. With Executive and Consultant Guides, Including Customized Forecasting and Analysis. 2022 to 2026" report has been added to ResearchAndMarkets.com's offering
DUBLIN--(BUSINESS WIRE)--Nov 11, 2022--
Proteomics is going mainstream. Where genomics couldn't find all the answers proteomics is stepping up to the plate.
Who will be the Illumina of Proteomics? Will these new biomarkers redefine disease definitions? Will Proteomic Assays displace current Genomic Assays? Find out all about it and more in this comprehensive report.
Proteomic Biomarker Analytics is just finding its feet, but the opportunity is to understand the front line players, the actual proteins and protein complexes, that do the work of managing cellular life. Players are reporting double digit growth. Venture capital is well involved.
This technology could possibly displace most cancer diagnostic protocols and save money at the same time. The report forecasts the market size out for five years for a number of different market segments.
This research makes you the expert in your organization. Get the publisher's research team working for you by ordering all, or a portion, of this comprehensive report. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don't worry, your order is available as a credit if you wish to upgrade to more information. As always, assistance, and additional specific data, is provided without additional charges.
1.2 Guide for Executives and Marketing Staff
1.3 Guide for Investment Analysts and Management Consultants
2 Introduction and Market Definition
2.1 What is Proteomic Biomarker Analytics?
2.2 Proteomics and Drug Development
3 Proteomic Biomarker Analytics - Guide to Technologies
3.1.1 Separation Techniques and Electrophoresis
3.1.5 Protein Complementation Assays and Interaction Screens
3.1.6 Protein Structure Prediction
4.1 Players in a Dynamic Market
4.1.1 Academic Research Lab
4.1.2 Diagnostic Test Developer
4.1.3 Genomic Instrumentation Supplier
4.1.3.1 Cell Separation and Viewing Instrumentation Supplier
4.1.4 Pharmaceutical/Reagent Supplier
4.1.5 Independent Testing Lab
4.1.6 Public National/Regional Lab
4.1.10 Certification Body
5.1 Factors Driving Growth
5.1.4 Technology Convergence
5.2 Factors Limiting Growth
5.2.2 Capacity Constraints
6 Proteomic Analytics Recent Developments
6.1 Recent Developments - Importance and How to Use this Section
6.1.1 Importance of These Developments
6.1.2 How to Use this Section
6.2 Deepmind AI Predicts 3D Structure of Every Protein
6.3 Quanterix Slashing Workforce by 25 Percent
6.4 Study Shows Potential of Nanomosaic's Platform for Biomarker Development
6.5 Exact Sciences Bolsters Plasma Proteomics Tech With $15M Purchase of Omicera
6.6 Prognomiq Exploring Multiomic Markers for Variety of Cancer Dx Applications
6.7 Octave Bioscience Building Evidence Base for Multiple Sclerosis Test
6.8 Proteomics Goes Public
7 Profiles of Key Proteomic Biomarker Analytic Companies
8 Global Proteomic Analytics Markets
9 Global Protein Analytics Markets - by Application
9.1 Protein Analytics Drug Discovery
9.2 Protein Analytics Research Application
9.3 Protein Analytics Clinical Dx
9.4 Protein Analytics Other Applications
10 Global Protein Analytics Markets - by Technology
10.1 Protein Analytics Mass Spectrometry
10.2 Protein Analytics Elisa/Beads
10.3 Protein Analytics Hybrid Multiplex
10.4 Protein Analytics Other Technology
11 Global Protein Analytics Markets - by Product
11.1 Protein Analytics Instruments
11.2 Protein Analytics Kits & Reagents
11.3 Protein Analytics Services
12 Global Protein Analytics Markets - by Place
12.1 Protein Analytics Academic
12.2 Protein Analytics Pharma/Biotech
12.3 Protein Analytics Clinical
12.4 Protein Analytics Other Place
Abbott Laboratories
Agilent/Dako
Basepair Biotechnologies
Beckman Coulter Diagnostics
Becton, Dickinson and Company
Bio-Rad Laboratories, Inc.
Cepheid (Danaher)
Eve Technologies
Fluidic Analytics
Hybrigenics Services
Luminex Corp
Nautilus Biotechnology
Nicoya
Olink
Qiagen
Quanterix
Roche Molecular Diagnostics
Siemens Healthineers
Somalogic
Thermo Fisher Scientific Inc.
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY
SOURCE: Research and Markets
Copyright Business Wire 2022.
PUB: 11/11/2022 05:56 AM/DISC: 11/11/2022 05:56 AM
http://www.businesswire.com/news/home/20221111005206/en